Results 101 to 110 of about 6,750 (143)

Efficacy and Safety of Tofacitinib in Palmoplantar Pustulosis: A Retrospective Study. [PDF]

Acta Derm Venereol
Lyu S, Xue X, Wang N, Liu H, Zhang F.
europepmc   +1 more source

From apremilast to JAK inhibitors-salvage treatment strategies for refractory palmoplantar pustulosis: case series. [PDF]

Front Med (Lausanne)
Pan Y, Jin D, Meng F, Zhang H, Tang J, Guo C, Li C, Ma J.   +7 more
europepmc   +1 more source

Targeting the JAK/STAT pathway in palmoplantar pustulosis: a review. [PDF]

Ann Med
Vimbai Chirindo C, Yun-Jie W, Tauseef H, Chao C, Tao Y.   +4 more
europepmc   +1 more source

Relapsing Polychondritis With Palmoplantar Pustulosis: A Case Report. [PDF]

Clin Med Insights Arthritis Musculoskelet Disord
Vasileios L, Olga K, Panayiotis VG.
europepmc   +1 more source

Summary of Research: Apremilast in Japanese Patients with Palmoplantar Pustulosis: A Randomized, Phase 3 Trial. [PDF]

Dermatol Ther (Heidelb)
Terui T, Okubo Y, Kobayashi S, Morita A, Imafuku S, Tada Y, Abe M, Strober B, Gooderham M, Hara Y, Zhang W, Shimauchi J, Yaguchi M, Kimura T, Ogawa R, Amouzadeh H, Murakami M.   +16 more
europepmc   +1 more source

Successful treatment of palmoplantar pustulosis with topical ruxolitinib. [PDF]

J Dtsch Dermatol Ges
Cramer N, Wellmann P, Schön MP, Mössner R.   +3 more
europepmc   +1 more source

Mycosis Fungoides Palmaris et Plantaris Mimicking Palmoplantar Pustulosis: A rare case report. [PDF]

J Dtsch Dermatol Ges
Wang J, Wen X, Wan R, Liu J, Wang L.
europepmc   +1 more source

Efficacy of upadacitinib in palmoplantar pustulosis case series highlights the complex immune response patterns. [PDF]

J Dtsch Dermatol Ges
Mai SZ, Xue RZ, Wu XY, Li GM, Liu LY, Chen DM, Chen LY, Zhang ZY.   +7 more
europepmc   +1 more source